Schriftgröße: 100 %
Article 1
1. The Community shall purchase as soon as possible the following strains of foot-and-mouth disease antigen:
- A Iran 96: 1000000 doses,
- A Iran 99: 1000000 doses,
- A Malaysia 97: 500000 doses,
- SAT1: 500000 doses,
- SAT2 (Southern Africa): 500000 doses,
- SAT2 (East Africa): 500000 doses,
- SAT3: 500000 doses.
2. The Community shall make arrangements for formulation, production, bottling and distribution of vaccines against foot-and-mouth disease produced from antigens referred to in paragraph 1.
3. The maximum cost of the measures referred to in paragraphs 1 and 2 shall be up to EUR 2,5 million.
4. The action referred to in paragraph 3 shall be organised by the Commission before 31 December 1999.
